細胞銀行外包市場規模、佔有率和成長分析（按類型、產品、細胞類型、階段和地區）- 產業預測 2025-2032

2023 年全球手機銀行外包市場規模價值 133 億美元，預計將從 2024 年的 155.9 億美元成長到 2032 年的 554.9 億美元，預測期內（2025-2032 年）的複合年成長率為 17.2%。

在冷凍保存和細胞庫準備技術的進步的推動下，全球細胞庫外包市場預計將顯著成長。幹細胞療法的普及以及對單株抗體和有效生物製藥的需求不斷增加，進一步推動了該領域的發展。 2020 年初，全球先進細胞療法臨床試驗數量激增 30%，凸顯了對細胞銀行服務日益成長的需求。政府的支持措施和細胞株保存和表徵方面的創新技術為市場擴張提供了動力。 Opsis Therapeutics 和 FUJIFILM Cellular Dynamics 等領先產業公司之間的合作正在推動研發工作，包括證明人類誘導多功能細胞在改善健康結果方面的有效性的研究。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

手機銀行外包市場規模（按類型和複合年成長率）（2025-2032）

• 市場概況
• 主細胞庫
• 病毒細胞庫
• 工作細胞庫

手機銀行外包市場規模（按產品和複合年成長率） (2025-2032)

• 市場概況
• 臍帶細胞儲存
• 成人幹細胞儲存
• 誘導性多功能幹細胞儲存
• 胚胎幹細胞儲存

細胞銀行外包市場規模（按細胞類型和複合年成長率） (2025-2032)

• 市場概況
• 幹細胞
  • 臍帶細胞儲存
  • 胚胎幹細胞儲存
  • 成人幹細胞儲存
  • 牙科幹細胞庫
  • IPS 幹細胞庫
• 非幹細胞

手機銀行外包市場規模（依階段分類）及複合年成長率（2025-2032）

• 市場概況
• 銀行儲存
  • 主細胞庫存儲
  • 工作細胞庫儲存
  • 細胞保存穩定性測試
• 細胞保存穩定性測試
• 銀行準備
  • 主細胞庫準備
  • 工作細胞庫的準備
• 銀行特性與測試
  • 安全測試
  • 病毒細胞庫
  • 微生物細胞庫
  • 基因表現檢測
  • 核子醫學檢查
  • 基因序列檢測

手機銀行外包市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Charles River Laboratories（USA）
• Lonza（Switzerland）
• Merck KGaA（Germany）
• SGS Societe Generale de Surveillance SA（Switzerland）
• Cryo-Cell International, Inc.（USA）
• LifeCell（India）
• WuXi AppTec（China）
• Eurofins Scientific（Luxembourg）
• Sartorius（Bio Outsource）（Germany）
• BSL Bioservice（Germany）
• Key Developments
• ViaCord（USA）
• StemCyte, Inc.（USA）
• Cryoviva Biotech Pvt. Ltd.（India）

結論和建議

Global Cell Banking Outsourcing Market size was valued at USD 13.3 billion in 2023 and is poised to grow from USD 15.59 billion in 2024 to USD 55.49 billion by 2032, growing at a CAGR of 17.2% during the forecast period (2025-2032).

The global cell banking outsourcing market is poised for substantial growth, fueled by advancements in cryopreservation and cell bank preparation techniques. The increasing prevalence of stem cell therapies, alongside a rising demand for monoclonal antibodies and effective biopharmaceuticals, is further propelling this sector. A notable 30% surge in global enrollments for advanced cell therapy trials in early 2020 underscores the escalating need for cell banking services. Supportive government initiatives and innovative technologies for cell line storage and characterization add momentum to market expansion. Collaborations among key industry players, such as Opsis Therapeutics and FUJIFILM Cellular Dynamics, bolster research and development efforts, exemplified by studies indicating the efficacy of human-induced pluripotent stem cells in enhancing health outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Banking Outsourcing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Banking Outsourcing Market Segments Analysis

Global Cell Banking Outsourcing Market is segmented by Type, Product, Cell Type, Phase and region. Based on Type, the market is segmented into Master Cell Banking, Viral Cell Banking and Working Cell Banking. Based on Product, the market is segmented into Cord Cell Banking, Adult Stem Cell Banking, Induced Pluripotent Stem Cell Banking and Embryonic Stem Cell Banking. Based on Cell Type, the market is segmented into Stem Cell and Non-Stem Cell. Based on Phase, the market is segmented into Bank Storage, Cell Storage Stability Testing, Bank Preparation and Bank Characterization and Testing. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cell Banking Outsourcing Market

A key factor propelling the global cell banking outsourcing market is the rising adoption of stem cell therapies, which is a burgeoning area within regenerative medicine known for its potential to address a variety of medical conditions. As the appetite for such therapies intensifies, the requirement for stable, high-quality cell lines becomes more pronounced, thereby boosting the demand for specialized cell banking services. Consequently, biopharmaceutical companies and contract research organizations (CROs) are increasingly turning to outsourcing for effective and economical solutions related to the production and preservation of these essential cell lines, ultimately driving market growth in this sector.

Restraints in the Global Cell Banking Outsourcing Market

A significant constraint on the global cell banking outsourcing market is the elevated cost associated with cell banking services. The cell banking process entails thorough testing and characterization to guarantee the quality and safety of cell lines, necessitating substantial investments in specialized equipment and infrastructure, which contributes to heightened service costs. Additionally, strict regulations enforced by regulatory authorities regarding the production and storage of cell lines further exacerbate expenses. Consequently, the high costs of these services may hinder their adoption, particularly in developing regions where healthcare budgets are constrained, creating a barrier to accessing essential cell banking solutions.

Market Trends of the Global Cell Banking Outsourcing Market

The Global Cell Banking Outsourcing market is currently witnessing a significant trend driven by the rising demand for personalized medicine which necessitates the use of genetically tailored cells for effective treatments. As healthcare evolves towards individualized approaches, cell banking firms are increasingly investing in advanced technologies and innovations to produce and store these specific cell types. This trend not only enhances treatment efficacy by aligning therapies with patients' unique genetic profiles but also propels market growth as more healthcare providers seek outsourcing solutions to streamline operations and improve patient outcomes. Consequently, the intersection of personalized medicine and cell banking is poised to reshape market dynamics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cell Banking Outsourcing Market Size by Type & CAGR (2025-2032)

• Market Overview
• Master Cell Banking
• Viral Cell Banking
• Working Cell Banking

Global Cell Banking Outsourcing Market Size by Product & CAGR (2025-2032)

• Market Overview
• Cord Cell Banking
• Adult Stem Cell Banking
• Induced Pluripotent Stem Cell Banking
• Embryonic Stem Cell Banking

Global Cell Banking Outsourcing Market Size by Cell Type & CAGR (2025-2032)

• Market Overview
• Stem Cell
  • Cord Cell Banking
  • Embryonic Stem Cell Banking
  • Adult Stem Cell Banking
  • Dental Stem Cell Banking
  • IPS Stem Cell Banking
• Non-Stem Cell

Global Cell Banking Outsourcing Market Size by Phase & CAGR (2025-2032)

• Market Overview
• Bank Storage
  • Master Cell Bank Storage
  • Working Cell Bank Storage
  • Cell Storage Stability Testing
• Cell Storage Stability Testing
• Bank Preparation
  • Master Cell Bank Preparation
  • Working Cell Bank Preparation
• Bank Characterization and Testing
  • Safety Testing
  • Viral Cell Banks
  • Microbial Cell Banks
  • Gene Expression Testing
  • Karyology Testing
  • Gene Sequencing Testing

Global Cell Banking Outsourcing Market Size & CAGR (2025-2032)

• North America (Type, Product, Cell Type, Phase)
  • US
  • Canada
• Europe (Type, Product, Cell Type, Phase)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Cell Type, Phase)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Cell Type, Phase)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Cell Type, Phase)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS Societe Generale de Surveillance SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryo-Cell International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeCell (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius (Bio Outsource) (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BSL Bioservice (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• ViaCord (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• StemCyte, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryoviva Biotech Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations